Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma

By Alejandro Forner1 , 2, R. Vilana, C. Ayuso, L. Bianchi, M. Solé, J. Ayuso, L. Boix, M. Sala, M. Varela, J. Llovet and 2 more. Hepatology, 2007

1,023 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. (2018, background): “HCC and are based on vascular phases (lesion appearance in the late arterial phase, in the portal venous phase, and in the delayed phase).(159,161,163) The typical hallmark is the combination of hypervascularity in late arterial phase (defined as arterial”
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. (2012, background): “5 and 2 cm detected within surveillance programs in cirrhotic patients showed that non-invasive criteria are accurate for the diagnosis of HCC, with a specificity of 100% [104].”
Management of hepatocellular carcinoma: An update (2011, neutral): “Forner et al.175 used contrast ultrasound and MRI to evaluate lesions smaller than 2 cm found on surveillance.”
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. (2012, background): “5 and 2 cm detected within surveillance programs in cirrhotic patients showed that non-invasive criteria are accurate for the diagnosis of HCC, with a specificity of 100% [104].”